Overview

Sublingual Ketorolac Compared to Intranasal Dexmedetomidine for Postoperative Analgesia in Pediatric Patients Undergoing Bilateral Myringotomy

Status:
Withdrawn

Trial end date:
2019-05-15

Target enrollment:

Participant gender:

Summary

The investigators aim to compare intranasal dexmedetomidine in a dose of 1ug.kg-1 with sublingual ketorolac in a dose of 1mg.kg-1 on postoperative behaviour in those children undergoing BMT during their PACU stay

Phase:

N/A

Details

Lead Sponsor:

Mansoura University

Treatments:

Dexmedetomidine
Ketorolac
Ketorolac Tromethamine